Cure Alzheimer's Fund

Our Approach: We have a plan to end Alzheimer's, guided by leading scientists in the field. We're making tremendous progress. Join us.

Our Story: In 2004, we came together to fund Alzheimer's research in a whole new way. It's already paying off.

Our Commitment: We put every dollar to work. Our founders cover all administrative costs, which means every penny you donate will go directly to new research.

Research Updates

Public/Private Funding of Research on Alzheimer's Disease Guides Drug Discovery

New Research Co-Funded by Cure Alzheimer’s Fund Shows New Alzheimer’s Gene, CD33, May Hold Key to Treatment

High levels of exposure to air pollution may increase the risk of Alzheimer’s disease, according to a new study completed with a grant from the Cure Alzheimer’s Fund.

Traumatic Brain Injury (TBI) can lead to Neurodegenerative Syndromes that include Alzheimer Disease (AD) and Chronic Traumatic Encephalopathy (CTE)

Researchers Reprogramming Skin Cells into Brain Cells to Understand Alzheimer's Disease

Cure Alzheimer's Funded Research: New Findings Overturn Commonly Held Views of the NMDA Receptors Creating New Targets in the Treatment of Alzheimer's Disease

Cure Alzheimer’s Fund's Potential New Treatment to Stop Alzheimer's Disease: Molecular 'Tweezers' Break Up Toxic Aggregations of Proteins in Mouse Model

Eli Lilly Drug Slows Decline in Early-Stage Patients

Cure Alzheimer's-seeded Research Bears Fruit in Major New NIH-funded Study

News

Art for Alzheimer’s

September 4, 2012 • Social Activism

After reading Barbara Kingsolver’s Animal Dreams in Honors English at Scituate High School, Lexie Fidas, 15, was given another class assignment—to...

Meet Cure Alzheimer's Fund Chairman and Co-Founder Jeffrey L. Morby

August 31, 2012

Chairman and Co-Founder Jeffrey L. Morby discusses the focus of Cure Alzheimer's Fund: to conquer the problem of Alzheimer's disease with a clearly...

Solanezumab Fails in Trial -- But May Still Help with Mild Alzheimer's

August 27, 2012 • Alzheimer's in the News

On Friday, August 24, Eli Lilly announced that their beta-amyloid immunotherapy (solanezumab) failed to meet its primary clinical endpoints for Alzheimer's...

Cure Alzheimer's Fund on NPR

August 23, 2012 • News

Cure Alzheimer's Fund co-founder & chairman, Jeff Morby, and lead scientist, Rudy Tanzi, Ph.D., discussed current developments in Alzheimer's...

David K. Johnson Foundation

August 21, 2012 • Social Activism

The David K. Johnson (DKJ) Foundation was created in 2000 in honor and memory of David and Susan Johnson of Reading, Mass., to promote awareness of and provide...

Cure Alzheimer's Fund is a 501(c)(3) public charity. Cure Alzheimer’s Fund is a "doing business as" name for the Alzheimer's Disease Research Foundation, federal tax ID # 52-2396428.

Cure Alzheimer's Fund meets all 20 BBB Charity Standards

GuideStar